Biotricity: Q4 Earnings Insights

Biotricity (NASDAQ:BTCY) reported its Q4 earnings results on Friday, June 30, 2023 at 08:00 AM. Here’s what investors…

Biotricity (NASDAQ:BTCY) reported its Q4 earnings results on Friday, June 30, 2023 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Biotricity beat estimated earnings by 11.11%, reporting an EPS of $-0.08 versus an estimate of $-0.09.

Revenue was up $590 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 3.33% drop in the share price the next day.

Here’s a look at Biotricity’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.090 -0.070 -0.110 -0.11
EPS Actual -0.079 -0.082 -0.085 -0.11
Revenue Estimate 2.40M 2.54M 2.19M 2.04M
Revenue Actual 2.46M 2.38M 2.06M 2.15M

To track all earnings releases for Biotricity visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Why Cimpress Stock Is Up After Earnings

Cimpress beat estimated earnings by 72.58%, reporting quarterly earnings of $2.14 per shares versus the analyst consensus estimate of $1.24. The company reported quarterly sales of $921.36 million which beat the analyst consensus estimate of $892.1 million by 3.28% and represents a 9% increase over sales of $845.20 million the same period last year.

CMPR